| Decision | Consent granted Section 13(1)(c) Overseas Investment Act 2005 |
|---|---|
| Decision maker | Toitū Te Whenua Land Information New Zealand |
| Decision date | 21 October 2025 |
| Pathway | Significant business assets only |
| Investment | Acquisition by Abbott Nutrition NZ Limited of substantially all of Synlait Milk Limited’s North Island assets. |
| Consideration | $307,000,000 |
| Applicant | Abbott Nutrition NZ Limited United States 81% United Kingdom 6% Various 13% |
| Vendor | Synlait Milk Limited China 65% New Zealand 27% Various 8% |
| Background | The Applicant is ultimately owned by Abbott Laboratories, a global healthcare company headquartered in the United States. With this investment the Applicant will acquire the bulk of the Vendor’s North Island assets. This includes a freehold interest in the Pōkeno manufacturing site, leasehold interests in an Auckland canning site and warehouse, along with associated business assets including plant and equipment. Consent was granted as the Applicant has met the investor test criterion. |
| More information | Susie Kilty Buddle Findlay PO Box 2694 Wellington 6140 |